Showing 181-190 of 8181 results for "".
Reviving the Dream: Correcting Suboptimal Results from Injectable Treatments
https://practicaldermatology.com/topics/general-topics/PD0309_10-php/22864/Skill, patience and meticulous selection of products and injection techniques are pre-requisites for satisfactory correction of a poor outcome from treatment with dermal fillers and botulinum toxin.?Understand and Correct Common Claim Denials
https://practicaldermatology.com/topics/general-topics/PD0109_09-php/22896/A review of some common causes for claim denials identifies strategies for obtaining proper reimbursement.Challenges and Opportunities for the Dermatology Specialty
https://practicaldermatology.com/topics/practice-management/challenges-and-opportunities-for-the-dermatology-specialty/23881/Joining together may help address some of the issues facing board-certified dermatologists.AAD Wrap: What To Know from Dermatology’s Biggest Meeting
https://practicaldermatology.com/issues/april-2025/aad-wrap-what-to-know-from-dermatologys-biggest-meeting/35623/The 2025 American Academy of Dermatology (AAD) Annual Meeting brought together the dermatology community this past March to exchange groundbreaking research, innovative treatments, and technological advancements. For 4 days in Orlando, the meeting served as the hub of the dermatology profession, delMaximizing Valuation and Outcomes for Practice Owners: A Conversation with Dana Jacoby
https://practicaldermatology.com/topics/practice-management/maximizing-valuation-and-outcomes-for-practice-owners-a-conversation-with-dana-jacoby/29889/Contributor Clint Bundy recently interviewed Dana Jacoby, President and CEO of Vector Medical Group, an operational and strategic consulting firm focused on the healthcare sector, to discuss building value in a dermatology and aesthetics practice and optimal ways to achieve full value for that businDERM2024 Meeting Wrap-Up
https://practicaldermatology.com/conferences/derm2024/derm2024-meeting-wrap/26974/DERM2024 Meeting Wrap-UpDiverse by Design: The Unique Molecular Footprints of IL-23 Biologics in Psoriasis
https://practicaldermatology.com/issues/april-2024/il23_biologics_in_psoriasis/24457/Christopher Bunick, MD, PhD, discusses a study that explores the structural basis of IL-23 targeted biologic therapies for psoriasis. By mapping the binding sites of these therapies on the IL-23 molecule and correlating molecular properties with clinical efficacy, the study offers insights into whyOne Doctor’s Legal Education Odyssey
https://practicaldermatology.com/topics/practice-management/one-doctors-legal-education-odyssey/23999/What happens when a seasoned dermatologist and dermatopathologist pursues his childhood dream of becoming a lawyer?Top Dermatology Marketing Trends for 2023
https://practicaldermatology.com/topics/practice-management/top-dermatology-marketing-trends-for-2023/23862/Are you up to date on trends in digital marketing?A Growing Neuromodulator Market: Daxxify Approved
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-growing-neuromodualtor-market-daxxify-approved/23797/Revance Therapeutics’ DaxibotulinumtoxinA-lanm is now approved to treat glabellar lines.